Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Endometrial cancer
ADR ID BADD_A01487
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.12      Reproductive neoplasms female malignant and unspecified
16.12.02      Endometrial neoplasms malignant
16.12.02.001      Endometrial cancer
21      Reproductive system and breast disorders
21.07      Uterine, pelvic and broad ligament disorders
21.07.02      Uterine neoplasms
21.07.02.002      Endometrial cancer
Description Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. [MeSH]
MedDRA Code 10014733
MeSH ID D016889
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Ca endometrium | Cancer of endometrium | Carcinoma endometrial | Endometrial cancer | Endometrial cancer NOS | Endometrial carcinoma | Endometrial carcinoma (NOS) | Endometrial neoplasm malignant | Malignant endometriosis | Endometrial Neoplasms | Endometrial Neoplasm | Neoplasm, Endometrial | Neoplasms, Endometrial | Endometrial Carcinoma | Carcinoma, Endometrial | Carcinomas, Endometrial | Endometrial Carcinomas | Endometrial Cancer | Cancer, Endometrial | Cancers, Endometrial | Endometrial Cancers | Endometrium Cancer | Cancer, Endometrium | Cancers, Endometrium | Cancer of the Endometrium | Carcinoma of Endometrium | Endometrium Carcinoma | Endometrium Carcinomas | Cancer of Endometrium | Endometrium Cancers
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01366Medroxyprogesterone acetate0.000119%
BADD_D01372Megestrol acetate--
BADD_D01445Metoprolol0.000007%
BADD_D01463Mifepristone--
BADD_D01507Mycophenolate mofetil--
BADD_D01567Nilotinib0.000112%
BADD_D01586Norethindrone acetate--
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01629Osimertinib0.000112%
BADD_D01630Ospemifene0.000270%
BADD_D01653Paclitaxel0.000246%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01835Pregabalin--
BADD_D01852Progesterone--
BADD_D01903Raloxifene--
BADD_D01913Ranitidine0.000113%
BADD_D01966Ropinirole--
BADD_D02100Sunitinib0.000168%
BADD_D02111Tamoxifen--
BADD_D02112Tamoxifen citrate--
BADD_D02165Teriflunomide0.000241%
BADD_D02213Tibolone--
BADD_D02236Tofacitinib0.000603%
BADD_D02250Toremifene citrate--
BADD_D02299Trisequens--
BADD_D02312Ulipristal--
BADD_D02331Valsartan0.000079%
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages
ADReCS-Target
ADR Term Drug Name Target